CA2654108A1 - Techniques permettant de traiter le choc septique - Google Patents

Techniques permettant de traiter le choc septique Download PDF

Info

Publication number
CA2654108A1
CA2654108A1 CA2654108A CA2654108A CA2654108A1 CA 2654108 A1 CA2654108 A1 CA 2654108A1 CA 2654108 A CA2654108 A CA 2654108A CA 2654108 A CA2654108 A CA 2654108A CA 2654108 A1 CA2654108 A1 CA 2654108A1
Authority
CA
Canada
Prior art keywords
polypeptide
amino acid
seq
septic shock
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2654108A
Other languages
English (en)
Inventor
Steve Hefeneider
Sharon L. Mccoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health Science University
US Department of Veterans Affairs VA
Original Assignee
Oregon Health Science University
US Department of Veterans Affairs VA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon Health Science University, US Department of Veterans Affairs VA filed Critical Oregon Health Science University
Priority to CA2654108A priority Critical patent/CA2654108A1/fr
Publication of CA2654108A1 publication Critical patent/CA2654108A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2654108A 2009-02-13 2009-02-13 Techniques permettant de traiter le choc septique Abandoned CA2654108A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2654108A CA2654108A1 (fr) 2009-02-13 2009-02-13 Techniques permettant de traiter le choc septique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2654108A CA2654108A1 (fr) 2009-02-13 2009-02-13 Techniques permettant de traiter le choc septique

Publications (1)

Publication Number Publication Date
CA2654108A1 true CA2654108A1 (fr) 2010-08-13

Family

ID=42558516

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2654108A Abandoned CA2654108A1 (fr) 2009-02-13 2009-02-13 Techniques permettant de traiter le choc septique

Country Status (1)

Country Link
CA (1) CA2654108A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112996586A (zh) * 2018-10-29 2021-06-18 陶氏环球技术有限责任公司 气体脱水

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112996586A (zh) * 2018-10-29 2021-06-18 陶氏环球技术有限责任公司 气体脱水
CN112996586B (zh) * 2018-10-29 2023-08-11 陶氏环球技术有限责任公司 气体脱水

Similar Documents

Publication Publication Date Title
US6191254B1 (en) Antimicrobial cationic peptides
TW201004640A (en) Treatment of inflammatory bowel diseases with mammal beta defensins
JP7428404B2 (ja) Ｇｓｘ１を使用した脊髄損傷（ｓｃｉ）および脳損傷の処置
US20100166708A1 (en) Antimicrobial and anti-inflammatory therapies and compositions
CN111870688B (zh) ACE2蛋白与IL-6或TNFα拮抗剂组合及其应用
CN112375149A (zh) Ace2免疫融合蛋白及其应用
AU2002215919B2 (en) Chemokine mutants in the treatment of multiple sclerosis
US20120178667A1 (en) Methods for treating septic shock
US6440690B1 (en) Peptides for the activation of the immune system in humans and animals
AU2002215919A1 (en) Chemokine mutants in the treatment of multiple sclerosis
US10548946B2 (en) Therapeutic compositions for neutralizing type I interferons, and methods of use
CA2654108A1 (fr) Techniques permettant de traiter le choc septique
AU2009200565A1 (en) Methods for treating septic shock
AU2009200566A1 (en) Methods for treating septic shock
US9850278B2 (en) Synthetic anti-inflammatory peptides and use thereof
JP2022508619A (ja) ニューロメジンペプチドを使用して２型サイトカイン媒介性炎症を低減させる方法
JP2020505324A (ja) シェーグレン症候群の治療用ペプチド
EP4159744A1 (fr) Nouveau peptide anti-inflammatoire et utilisation associée
CN112043819B (zh) Lapf及其相关物质在抗感染中的应用
WO2008006467A1 (fr) Peptide antimicrobien dérivé du peptide associé au message de la galanine (gmap)

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20150213